Wellgistics Health, Inc.
Qualité des données : 100%
WGRX
Nasdaq
Wholesale Trade
Nondurable Goods Wholesale
0,11 €
▼
0,02 €
(-15,87%)
Cap. Boursière: 12,74 M
Prix
0,11 €
Cap. Boursière
12,74 M
Fourchette du Jour
0,10 € — 0,12 €
Fourchette 52 Semaines
0,10 € — 7,04 €
Volume
9 357 272
Ouverture 0,12 €
Moyenne 50J / 200J
0,23 €
53,12% below
Moyenne 50J / 200J
0,65 €
83,77% below
Quick Summary
Points Clés
Debt/Equity of 3,66 — high leverage
Negative free cash flow of -5,79 M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-22,32%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-2089,68%
En dessous de la moyenne du secteur (-3,22%)
ROIC-369,67%
Net Margin-201,72%
Op. Margin-187,31%
Sécurité
Debt / Equity
3,66
Au-dessus de la moyenne du secteur (0,33)
Current Ratio0,39
Interest Coverage-16,44
Valorisation
PE (TTM)
-0,16
En dessous de la moyenne du secteur (-0,15)
P/B Ratio1,88
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Wholesale Trade (91 pairs)
Comparaison Sectorielle
vs médiane du secteur Wholesale Trade (91 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -0,2 | -0,2 |
| P/B | 1,9 | 1,0 |
| ROE % | -2089,7 | -3,2 |
| Net Margin % | -201,7 | -2,2 |
| Rev Growth 5Y % | — | 2,6 |
| D/E | 3,7 | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -22,32% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 39,80 M | Net Income (TTM) | -80,28 M |
| ROE | -2089,68% | ROA | -150,05% |
| Gross Margin | 8,03% | Operating Margin | -187,31% |
| Net Margin | -201,72% | Free Cash Flow (TTM) | -5,79 M |
| ROIC | -369,67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 3,66 | Current Ratio | 0,39 |
| Interest Coverage | -16,44 | Asset Turnover | 0,74 |
| Working Capital | -19,92 M | Tangible Book Value | -11,69 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,16 | Forward P/E | N/A |
| P/B Ratio | 1,88 | P/S Ratio | 0,32 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -45,44% | ||
| Market Cap | 12,74 M | Enterprise Value | 33,32 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,33 | Revenue / Share | 0,33 |
| FCF / Share | -0,05 | OCF / Share | -0,05 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 7,21% |
| SBC-Adj. FCF | -6,87 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenue | 18,13 M | 23,34 M |
| Net Income | -6,86 M | -101,27 M |
| EPS (Diluted) | -0,15 | -1,43 |
| Gross Profit | 1,77 M | -6,43 M |
| Operating Income | -6,15 M | -93,75 M |
| EBITDA | — | — |
| R&D Expenses | — | — |
| SG&A Expenses | — | — |
| D&A | 1,11 M | 3,21 M |
| Interest Expense | 831 467,0 | 4,58 M |
| Income Tax | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2025 |
|---|---|---|
| Total Assets | 57,33 M | 30,46 M |
| Total Liabilities | 50,60 M | 42,91 M |
| Shareholders' Equity | 6,73 M | -12,45 M |
| Total Debt | 23,38 M | 23,49 M |
| Cash & Equivalents | 1,03 M | 42 571,0 |
| Current Assets | 15,17 M | 2,82 M |
| Current Liabilities | 38,05 M | 29,78 M |
{"event":"ticker_viewed","properties":{"ticker":"WGRX","listing_kind":"stock","pathname":"/stocks/wgrx","exchange":"Nasdaq","country":"US"}}